Home / Work / Pharma marketing

The pharma creative that stopped dying at legal review

A 70-person independent pharma-marketing agency running display ads in the US and Canada saw most of its creative rejected at regulatory review, often after the client had already approved the concept.

The problem

Ad creative keeps getting rejected at legal review after client approval

What was built

We codified US and Canadian pharma display-advertising rules into tests, using the agency's past rejection history to show how each rule gets applied. Creatives submit ideas, visuals or copy to an internal portal at the sketch stage. It returns plain-language failures, never approves, and lists what it cannot judge, so counsel still decides.

What it measured
Built with

Same problem?Send it over.

Tell me what your version looks like and which tools it runs in. I reply with how I would build it.

Email Eugene
More work